The FDA plans to update the label of montelukast sodium (Singulair, Merck) zafirlukast (Accolate, AstraZeneca), and zileuton (Zyflo, Cornerstone) with a precaution concerning neuropsychiatric events such as agitation, depression, insomnia, and suicidal thinking.
Zoledronic acid injection (Reclast, Novartis) has been approved as the first therapy to prevent postmenopausal osteoporosis for two years with a single dose.
In a study involving more than 500 postmenopausal women with osteopenia, a single infusion significantly increased bone mineral density at two years compared with placebo.
NeurogesX, Inc., has announced the approval of an orphan drug designation for Qutenza (formerly NGX-4010), a high-concentration capsaicin dermal patch, to manage neuropathic pain in patients with postherpetic neuralgia (PHN). PHN is a chronic condition that develops following a herpes zoster (shingles) outbreak. Current therapies for PHN include antidepressants, anticonvulsant agents, topical anesthetics, and opioid analgesics.
If I were to recommend a specific product for the anxiety and panic Joe Barry Panic Away is suffering from a program that has helped me most. If you suffer from generalized anxiety, panic attacks, social anxiety, obsessive compulsive disorder, phobias or agoraphobia Panic Away program is to work with them. There are chapters on specific phobias such as fear of driving and public space. Joe Barry is very good at explaining his techniques in a clear and simple sense of style. It is so confident in their program of panic that says all, without exception, can be used to your fear.
The FDA has approved besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch & Lomb), a topical eyedrop for patients with nonviral bacterial conjunctivitis.
Bacterial forms of conjunctivitis are common in childhood, but they can occur in people of any age. Symptoms can include reddened eyes, swelling, eyelids sticking together, itching, watering, and a sticky discharge from the eyes. The course usually lasts for 7 to 14 days.
Researchers from the National Institutes of Health (NIH) have discovered five genetic variants related to blood pressure (BP) in African-Americans. This genome-wide association study may provide new clues to treating and preventing hypertension in this population.
Antibiotic resistance is making it more difficult to treat common urinary tract infections (UTIs). Resistance to betalactam antibiotics prompted a switch to trimethoprim drug/sulfamethoxazole (TMP/ SMX, Bactrim); however, this agent was also susceptible to resistance, and fluoroquinolones became the new first-line choice.
